What is EyeControl?
EyeControl specializes in adaptive patient communication solutions designed to enhance interaction across diverse healthcare settings. Their innovative products are engineered to support patients throughout their recovery journey, from sedation to post-operative care, effectively restoring their ability to communicate and engage in their own treatment. The company's mission is to empower medical professionals and families by furnishing tools that foster compassionate and responsive patient care, ultimately aiming to improve clinical outcomes and elevate the overall patient and family experience.
How much funding has EyeControl raised?
EyeControl has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2020): $10M, investors not publicly disclosed
What's next for EyeControl?
The recent major strategic investment positions EyeControl for significant expansion and further development of its adaptive communication technologies. This capital infusion is expected to accelerate product innovation, broaden market reach, and enhance operational capabilities. The company's focus on empowering patients and healthcare providers suggests a trajectory towards becoming a leader in assistive communication, potentially exploring new applications and partnerships to solidify its market presence and drive further growth.
See full EyeControl company page
